Skip to content

643 applications due to vaccination damage: AfD criticizes success rate

643 applications due to vaccination damage: AfD criticizes success rate

643 applications due to vaccination damage: AfD criticizes success rate
643 applications due to vaccination damage: AfD criticizes success rate

In the Saxon region, a staggering 643 applications for compensation due to Corona vaccine-related side effects have been submitted. After analyzing these claims, the Federal Ministry of Health (BMG) has rejected 452 applications and approved just 27 thus far. The AfD parliamentary group in Saxony raised eyebrows over the unsatisfactory success rate of these claims, with André Wendt labeling it a "slap in the face" for those affected and their families. The critique stems from the impression that Saxony only seems interested in doling out small settlements with no real intention of conducting a thorough examination of the "Corona injustice."

To put things into context, these 643 compensation claims stand in stark contrast to the almost 7.7 million Corona vaccinations administered in Saxony.

Some Insights

While the details behind the high rejection rate of Corona vaccine damage claims in Saxony remain unclear, there are a few factors that could potentially impact this situation:

  1. Legal Challenges: Germany's high court has issued several rulings against various pandemic-related measures, including the rejection of a vaccine mandate for adults older than 60. These decisions might influence the handling of compensation claims.
  2. Fraud and Administrative Issues: Past incidents of fraud in the free coronavirus testing scheme could have impacted the processing of compensation claims. As a response, the government introduced tighter controls and reduced financial support, but disputes over who is responsible for such fraud may still complicate matters.
  3. Stringent Criteria for Proving Damage: Given the strict public health measures and mandatory vaccinations in Germany, the standards for demonstrating Corona vaccine-related damage might be prohibitively high. Consequently, many claims may lack sufficient evidence to support approval.

Of course, without specific insights into the current status of compensation applications in Saxony, these factors remain speculations until further data surfaces. Regardless, the situation underscores the importance of considering just compensation for individuals who have experienced negative side effects from the Corona vaccine.

Latest